Center-Authored Papers

Filters: Author is Richardson, Paul  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
Bajwa RPS, Mahadeo KM, Taragin BH, Dvorak CC, McArthur J, Jeyapalan A, Duncan CN, Tamburro R, Gehred A, Lehman L et al..  2017.  Consensus Report by PALISI and PBMTC Joint Working Committees, Supportive Care Guidelines for Management of VOD in Children and Adolescents Part 1: Focus on Investigations, Prophylaxis and Specific Treatment.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. Abstract
C
Chen I, Clarke W, Ou S-S, Marzinke MA, Breaud A, Emel LM, Wang J, Hughes JP, Richardson P, Haley DF et al..  2015.  Antiretroviral Drug Use in a Cohort of HIV-Uninfected Women in the United States: HIV Prevention Trials Network 064.. PloS one. 10(10):e0140074. Abstract
Coovadia HM, Brown ER, Fowler MG, Chipato T, Moodley D, Manji K, Musoke P, Stranix-Chibanda L, Chetty V, Fawzi W et al..  2012.  Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial.. Lancet. 379(9812):221-8. Abstract
F
Fogel JM, Mwatha A, Richardson P, Brown ER, Chipato T, Alexandre M, Moodley D, Elbireer A, Mirochnick M, George K et al..  2012.  Impact of Maternal and Infant Antiretroviral Drug Regimens on Drug Resistance in HIV-Infected Breastfeeding Infants.. The Pediatric infectious disease journal. Abstract
Fowler MG, Coovadia H, Herron CM, Maldonado Y, Chipato T, Moodley D, Musoke P, Aizire J, Manji K, Stranix-Chibanda L et al..  2013.  Efficacy and safety of an extended nevirapine regimen in infants of breastfeeding mothers with HIV-1 infection for prevention of HIV-1 transmission (HPTN 046): 18-month results of a randomized, double-blind, placebo-controlled trial.. Journal of acquired immune deficiency syndromes (1999). Abstract
G
Gulick RM, Wilkin TJ, Chen YQ, Landovitz RJ, Amico RK, Young AM, Richardson P, Marzinke MA, Hendrix CW, Eshleman SH et al..  2017.  Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women: A Phase 2 Randomized Trial.. Annals of internal medicine. :1-10. Abstract
Gulick RM, Wilkin TJ, Chen YQ, Landovitz RJ, Amico RK, Young AM, Richardson P, Marzinke MA, Hendrix CW, Eshleman SH et al..  2016.  PHASE 2 STUDY OF THE SAFETY AND TOLERABILITY OF MARAVIROC-CONTAINING REGIMENS TO PREVENT HIV INFECTION IN MEN WHO HAVE SEX WITH MEN (MSM) (HPTN 069/ACTG A5305).. The Journal of infectious diseases. Abstract
H
Hendrix CW, Andrade A, Bumpus NN, Kashuba A, Marzinke MA, Moore A, Anderson PL, Bushman LR, Fuchs EJ, Wiggins I et al..  2015.  Dose Frequency Ranging Pharmacokinetic Study of Tenofovir-Emtricitabine after Directly Observed Dosing in Healthy Volunteers to establish Adherence Benchmarks (HPTN 066).. AIDS research and human retroviruses. Abstract
J
Jackson BJ, Wei L, Liping F, Aramrattana A, Celentano DD, Walshe L, Xing Y, Richardson P, Jun M, Beauchamp G et al..  2014.  Prevalence and seroincidence of hepatitis B and hepatitis C infection in high risk people who inject drugs in china and Thailand.. Hepatitis research and treatment. 2014:296958. Abstract
K
Kaleebu P, Njai HF, Wang L, Jones N, Ssewanyana I, Richardson P, Kintu K, Emel L, Musoke P, Fowler MG et al..  2013.  Immunogenicity of ALVAC-HIV vCP1521 in Infants of HIV-1 Infected Women in Uganda (HPTN 027): the first pediatric HIV vaccine trial in Africa.. Journal of acquired immune deficiency syndromes (1999). Abstract
Kintu K, Andrew P, Musoke P, Richardson P, Asiimwe-Kateera B, Nakyanzi T, Wang L, Fowler MG, Emel L, Ou S-S et al..  2012.  Feasibility and Safety of ALVAC-HIV vCP1521 Vaccine in HIV- exposed Infants in Uganda: Results from the First HIV Vaccine Trial in Infants in Africa.. Journal of acquired immune deficiency syndromes (1999). Abstract
L
Lucas GM, Young A, Donnell D, Richardson P, Aramrattana A, Shao Y, Ruan Y, Liu W, Fu L, Ma J et al..  2014.  Hepatotoxicity in a 52-week randomized trial of short-term versus long-term treatment with buprenorphine/naloxone in HIV-negative injection opioid users in China and Thailand.. Drug and alcohol dependence. Abstract
M
Metzger DS, Donnell D, Celentano DD, Jackson BJ, Shao Y, Aramrattana A, Wei L, Fu L, Ma J, Lucas GM et al..  2015.  Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058.. Journal of acquired immune deficiency syndromes (1999). 68(5):554-61. Abstract
Mirochnick M, Taha T, Kreitchmann R, Nielsen-Saines K, Kumwenda N, Joao E, Pinto J, Santos B, Parsons T, Kearney B et al..  2014.  Pharmacokinetics and safety of tenofovir in HIV-infected women during labor and their infants during the first week of life.. Journal of acquired immune deficiency syndromes (1999). 65(1):33-41. Abstract
P
Piwowar-Manning E, Fogel JM, Richardson P, Wolf S, Clarke W, Marzinke MA, Fiamma A, Donnell D, Kulich M, Mbwambo JKK et al..  2015.  Performance of the fourth-generation Bio-Rad GS HIV Combo Ag/Ab enzyme immunoassay for diagnosis of HIV infection in Southern Africa.. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 62:75-9. Abstract
R
Richardson P, Jagannath S, Hussein M, Berenson J, Singhal S, Irwin D, Williams SF, Bensinger WI, Badros AZ, Vescio R et al..  2009.  Safety and efficacy of single-agent lenalidomide in patients with relapsed and refractory multiple myeloma.. Blood. 114(4):772-8. Abstract
W
Watts HD, Brown ER, Maldonado Y, Herron C, Chipato T, Reddy L, Moodley D, Nakabiito C, Manji K, Fawzi W et al..  2013.  HIV Disease Progression in the First Year after Delivery among African Women followed in the HPTN 046 Clinical Trial.. Journal of acquired immune deficiency syndromes (1999). Abstract